Unsaturated fats may not always be anti-inflammatory, study finds
Unsaturated fats, such as those found in oily fish, nuts, seeds, avocados, and olive oil, are recommended as part of a healthful diet.Studies have linked these fatty acids to reduced levels of inflammation and lowered LDL ('bad') cholesterol.However, a new study suggests that both omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) are linked to increased levels of some inflammatory markers in the blood.Oily fish, nuts, seeds, avocados, and olive oil are all advocated as part of a healthful diet, mostly because of their high concentrations of unsaturated fatty acids. Studies suggest that unsaturated fatty acids, particularly omega-3, may reduce both inflammation, and levels of low-density lipoprotein, LDL or 'bad' cholesterol, which is linked to heart disease.However, a new study has suggested that polyunsaturated fatty acids may actually increase levels of some inflammatory biomarkers in the blood plasma.The research, which is published in The International Journal of Epidemiology, found that both omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) were associated with raised levels of glycoprotein acetyls (GlycA), biomarkers associated with increased cardiovascular risk.Links to inflammatory biomarkers in the bloodThe researchers carried out their primary analysis on 2,802 participants from the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort, which recruited a total of 14, 541 pregnant women residing in southwest England in 1991 and 1992, and has followed them and their offspring since then. They replicated their analysis using data from 12,401 participants in the UK Biobank.'Using two large datasets, ALSPAC and the UK Biobank, along with a genetic technique called Mendelian randomization, the researchers examined whether these fats cause changes in inflammation, rather than just being associated with it, exploring actual causality. This approach is especially powerful because it helps minimize the usual confounding factors found in nutrition studies, such as lifestyle or other dietary habits. In other words, the researchers went beyond asking who has more inflammation and what they eat and instead tried to determine whether the fats themselves were directly responsible.'— Thomas M. Holland, MD, MS, physician-scientist and assistant professor at the RUSH Institute for Healthy Aging, RUSH University, College of Health Sciences, Chicago, who was not involved in the study.The researchers assessed the ALSPAC offspring after 24 years. In their analysis, they controlled for household social class at birth, maternal highest education qualification at birth, maternal and paternal smoking status during pregnancy, offspring sex at birth, type of drinker at age 24 , type of smoker at 24 , and at age in months at 24-year clinic.Daisy Crick, corresponding author, Institute for Molecular Bioscience, Queensland University, Australia, and MRC Integrative Epidemiology Unit, The University of Queesland, Australia, explained their research:'Dietary fatty acids were measured using levels of DHA, total omega-3 LA, total omega-6, and the omega-6:omega-3 ratio found in the blood. Inflammation was measured using substances in the blood called biomarkers and specifically we used the biomarkers C-reactive protein (CRP), Interleukin-6 (IL-6) and Glycoprotein Acetyls (GlycA).'Can omega-3s be inflammatory?The researchers found that in both cohorts, both omega-3 and omega-6 levels were associated with higher levels of GlycA.Holland told Medical News Today:'Surprisingly, the results showed that both omega-3 and omega-6 fatty acids were associated with higher levels of a marker called GlycA (a novel inflammatory marker), which reflects low-grade chronic inflammation. This was unexpected, especially for omega-3s, which are widely promoted as anti-inflammatory.''Omega-3s are found in dark fatty fish, like salmon and sardines, and in plant-based foods like flaxseeds, chia seeds, and walnuts. Most people think of them as calming to the immune system. Yet in this study, higher omega-3 levels were linked to more inflammation, not less, at least when GlycA was used as the measurement,' he added.Omega-6 to omega-3 fatty acid ratio could be keyIn the ALSPAC cohort, there was a consistent association between a higher omega-6:omega-3 ratio and all three inflammatory biomarkers.Holland told us that this ratio is influenced by our changed diet:'This [finding] supports earlier findings that it's not just about how much omega-3 you consume; it's about how balanced your overall intake is. In fact, research highlights how this ratio has shifted dramatically in recent history. A century ago, people typically consumed a 4:1 ratio of omega-6 to omega-3. Today, due to modern diets rich in industrial seed oils, that ratio has ballooned to around 15:1 to 20:1. This shift creates a pro-inflammatory environment that could be contributing to chronic diseases, allergies, and autoimmune disorders.''Our findings suggest that it's not as simple as 'omega-3 is anti-inflammatory, and omega-6 is pro-inflammatory'. Just increasing the consumption of omega-3 through diet or supplements might not be enough to lower inflammation. Instead, our results suggest that it might be more useful to look at the balance or ratio between omega-6 and omega-3 in the diet. Improving the balance between the two fats could be a better method for people who want to reduce inflammation in their bodies.'— Daisy CrickThe link between fatty acids and health is complexAlthough the study found an association between PUFAs and some of the 3 biomarkers, the authors emphasize that different biomarkers measure different aspects of inflammation, so by assessing only 3 biomarkers, they may have missed some important effects of PUFAs on inflammation. Further research using additional biomarkers is needed to better understand the relationship between PUFAs and inflammation.Holland told MNT that these findings should lead to further research: 'It is important to remember that the study measured just three inflammatory markers. The immune system is incredibly complex, and omega fatty acids might influence other pathways that weren't captured here. For example, omega-3s might still help resolve short-term inflammation or protect against specific diseases, even if they raise GlycA slightly. More research using a broader range of immune biomarkers will help clarify this relationship.'Despite this limitation, the findings highlight that there may be more to the relationship between fatty acids and health than previously thought.'The relationship between fatty acids and inflammation is complex and our findings only tell part of the story. Although we show that omega-3 fats are associated with increases in some biomarkers of inflammation, it does not rule out other potential beneficial effects of these fatty acids in the diet.'— Daisy Crick
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
18 minutes ago
- Times
Martha's Rule saving lives as families use right to second opinion
The NHS has said that Martha's Rule is 'undoubtedly saving lives' in England — and doctors and bereaved parents have called for it to be expanded to Wales. The scheme was launched last year in 143 hospitals, allowing concerned family members of hospital patients to contact a critical care outreach team and request an urgent second opinion. Data shows that, from September to February, 129 patients in England received lifesaving medical interventions following the Martha's Rule review, including 57 being moved to a high dependency or intensive care unit. In total there were 2,389 calls made under Martha's Rule in the first six months of the scheme. One in five of these — 465 cases in total — led to a change of care such as different medication or life-saving urgent intervention.
Telegraph
an hour ago
- Telegraph
Paramedic's brain tumour missed five times by doctors
A paramedic has said her brain tumour was missed five times by doctors. Hannah Lemanski, 24, thought she was experiencing symptoms of stress from shift work when she complained to medics about vomiting, headaches, and double vision. She first visited her GP in February 2023 after experiencing headaches and vision problems for two months, but was sent home with no answer and told her symptoms would be passed on to another doctor. On her fourth visit to the GP she was told she had a lazy eye. After a fifth visit to the eye assessment clinic, an MRI scan diagnosed her with central neurocytoma – a rare brain tumour which grows in the ventricles of the brain. She had 80 per cent of the tumour removed in surgery but two years on it is returning. Doctors recommended gamma-knife radiosurgery to shrink the mass but this is not funded by NHS England for her specific tumour type. The treatment is recognised by the NHS and used to treat various health conditions, including brain tumours, both benign and cancerous. She is now fundraising to get the treatment privately. Ms Lemanski, from Middlesborough, said she thought she was going to die when she was first told of her diagnosis. Her wedding to her now-husband, Przemek Lemanski, 34, who was delivering invitations at the time of the diagnosis, had to be delayed. She underwent surgery to remove 80 per cent of the tumour James Cook hospital in May 2023 and returned to work as a paramedic. During a routine scan in March 2025, she was told her tumour is returning. The NHS offers conventional radiotherapy, a destructive treatment which can lead to more cancer developing, but doctors told Hannah the most effective treatment is gamma-knife surgery – a non-invasive and highly targeted form of radiotherapy. But Ms Lemanski was told by The National Centre for Stereotactic Radiosurgery in Sheffield's Royal Hallamshire Hospital that they don't offer this treatment for her condition – and said NHS England does not commission funds for this treatment and her specific tumour type. She applied for individual funding, but this was rejected. She said: 'It's quite upsetting. You pay your taxes every month and you expect to be looked after when you need it. How can you not look after one of your own? 'Maybe if I wasn't someone who worked for the NHS, I might have just accepted the conventional radiotherapy route, which I think for anyone of a young age without cancer puts them at so much higher risk, especially when there's more effective treatments out there. 'I think it's quite discriminatory really, because I don't understand why someone's brain tumour is better than mine.' Her friend Becky Calpin, 32, has raised over £12,000 to help Ms Lemanski get private treatment, but it could cost up to £20,000. Becky said: 'Hannah is more than a paramedic – she's a bright, healthy, active young woman, married to her best friend and dreaming of starting a family. 'She's the kind of person who lights up every room – always smiling, always giving, always ready to help.' An NHS England spokesperson said: 'We understand the importance of making decisions quickly to avoid unnecessary distress and, where treatment isn't routinely funded, clinicians can submit an individual funding request if there are exceptional clinical reasons. 'The NHS funds specialist stereotactic radiosurgery and radiotherapy for some cancers where there is evidence of a clinical benefit over standard treatments, as part of the personalised care provided for patients.'
Times
an hour ago
- Times
Third delay to ME care plan prompts backlash from patients
Health ministers have delayed a plan for the future treatment of the debilitating condition myalgic encephalomyelitis (ME) for the third time in nine months. Work on the ME Delivery Plan — which the government claims will boost research, advance medical education and improve patients' lives — began more than three years ago under the Conservative health secretary, Sajid Javid. Labour ministers have repeatedly pledged to publish the plan and have yet to explain why it has been delayed. Last October the public health minister at the time, Andrew Gwynne, said the government planned to publish 'in the winter of 2024/25'. In December, responding to the inquest into the death of the ME patient, Maeve Boothby O'Neill, 27, the minister told a coroner 'we aim to publish by the end of March'. On June 5, Gwynne's successor, Ashley Dalton, said it was 'a priority for the department to publish the final ME delivery plan by the end of June 2025'. On Saturday, however, a health department spokesperson would only say the plan would be published 'shortly'. ME, also known as chronic fatigue syndrome (CFS) affects at least 400,000 people in England and Wales. Many people with long Covid experience similar symptoms. The illness is characterised by extreme fatigue, disturbed sleep that does not bring rest and a flare-up of symptoms after even mild exertion (known as post exertional malaise). It is usually triggered by a viral infection and there is no proven cure or treatment. About 25 per cent of sufferers become severely ill with many housebound or bedbound. In a small number of cases patients die. The Times understands the ME initiative has been put on the back burner because the health secretary, Wes Streeting, is determined that nothing should distract from the promotion of his ten-year plan for the NHS. In a further blow to the hopes of ME patients, Streeting has also ruled out any new money for the delivery plan and rejected appeals for a ring-fenced fund to advance ME research. The plea for a specific funding resource was made in a letter signed by all 72 Liberal Democrat MPs. But the health secretary has written back saying ring fencing ME funding 'goes against our commitment to open competition to ensure transparency and scientific excellence'. His statement appears to contradict previous government awards such as the £50 million five-year commitment made in 2021 to finance research into Motor Neurone Disease while last year the National Institute for Health and Care Research (NIHR) called for proposals to address 'evidence gaps in liver disease research'. The NIHR is also running an 'open call' for a five-year research consortium to prevent cardiovascular disease. ME campaigners had lobbied for a similar scheme to build a research network and are surprised by Streeting's response. Helen Morgan, the Liberal Democrat health spokesperson, said people with ME and their carers had been left behind for decades. 'They have faced inadequate care, scant research funding, no treatments and little hope of a better future,' she said. 'Further delay to the Delivery Plan for ME is inexcusable. People with ME are right to feel that improving this situation is not a priority for this government. The government must think again, publish the plan without delay and allocate it the resources it needs to make a real difference.' • Severely ill patient with ME begs for home feeding Sonya Chowdhury, of the charity Action for ME, said she was 'deeply dismayed' by another delay to the delivery plan: 'Just weeks ago, the minister gave a public commitment that the plan would be published by the end of June. This is now the third delay in nine months, and the government's language around publication has become increasingly vague. 'The ME community is once again left in the dark — with no clear timeline, no explanation, and growing doubt over whether the plan will appear at all. What message does this send to a group already fighting for basic recognition, where the most severely affected are so often the most neglected?' A Department of Health and Social Care spokesperson said: 'Our thoughts are with all those whose lives have been touched by myalgic encephalomyelitis/chronic fatigue syndrome. We are committed to improving the care and support for all those affected and will publish a final delivery plan shortly.'
